enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
2.410
+0.130 (5.70%)
At close: Nov 13, 2026, 4:00 PM EST
2.319
-0.091 (-3.78%)
After-hours: Nov 13, 2026, 7:58 PM EST
enGene Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Nov 13, 2026 |
| Leerink Partners | Leerink Partners | Buy Upgrades $5 | Buy | Upgrades | $5 | +107.47% | Nov 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $4 | Buy | Reiterates | $4 | +65.98% | Nov 12, 2026 |
| Piper Sandler | Piper Sandler | Buy Upgrades $4 | Buy | Upgrades | $4 | +65.98% | Nov 12, 2026 |
| Wells Fargo | Wells Fargo | Buy Upgrades $2 → $6 | Buy | Upgrades | $2 → $6 | +148.96% | Nov 12, 2026 |
| UBS | UBS | Hold Reiterates $2 | Hold | Reiterates | $2 | -17.01% | Sep 16, 2026 |
| Morgan Stanley | Morgan Stanley | Sell Maintains n/a | Sell | Maintains | n/a | n/a | Aug 12, 2026 |